Funding Round Up March 2024

Funding Opportunities

Point-of-Care Technology Research Network

POCTRN 2024 Solicitation: Now Accepting Applications

Point-of-Care Technologies for HIV/AIDS, Co-morbidities, and Emerging Infectious Disease in Low- and Middle-Income Countries

Pre-proposal Due: March 31, 2024 8:59PM PT

Do you have a groundbreaking point-of-care technology in need of development? The National Institute of Biomedical Imaging and Bioengineering’s (NIBIB) Point-of-Care Technology Research Network (POCTRN) is pleased to announce six new funding opportunities from its centers.

California National Primate Research Center Pilot Funding Opportunity

CNPRC 2024 Call for Pilot Project Letters of Intent

LOI Due: March 18, 2024

Proposal Due: April 30, 2024

The California National Primate Research Center (CNPRC) Pilot Program invites Letters of Intent for pilot project proposals to support basic and translational research using nonhuman primates (rhesus macaques or titi monkeys) for the 2024-2025 base grant funding period.

HIV, Infectious Diseases and Global Health Implementation Research Institute (HIGH IRI)

2024 Call For Applications - HIV, Infectious Diseases and Global Health Implementation Research Institute (HIGH IRI)

Application Due: March 25, 2024

HIGH IRI will provide mentored training for dissemination & implementation research focused on HIV, Infectious Diseases and Global Health.

Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)

LOI Due: May 30, 2024

Application Due: July 30, 2024

NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)

LOI Due: September 13, 2024

Application Due: October 13, 2024

Notice of Special Interest (NOSI): Interventions to Reduce Chronic Inflammation and Inflammation-Related Morbidity in People Living with HIV/AIDS

The National Center for Complementary and Integrative Health (NCCIH) and other participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICOs) are soliciting projects to evaluate and elucidate interventions to prevent, reduce, and/or reverse chronic systemic inflammation and inflammation-related comorbidities and complications in people living with HIV/AIDS (PWH).

Request for Information (RFI) to inform development of the FY 2026-2030 NIH Strategic Plan for HIV and HIV-Related Research

Responses must be submitted electronically via the following website: https://rfi.grants.nih.gov/?s=65b25017cf031643470daad2

Responses must be received by March 28, 2024 at 11:59PM EST

Through this Request for Information (RFI), the Office of AIDS Research (OAR) in the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), National Institutes of Health (NIH), invites feedback from researchers, health care professionals, advocates and health advocacy organizations, scientific or professional organizations, federal/state/local government agencies, community, and other interested constituents on the development of the fiscal year (FY) 2026-2030 NIH Strategic Plan for HIV and HIV-Related Research (the Plan). The Plan guides the NIH investment, building on scientific progress and opportunities for advancing HIV/AIDS research toward an end to the pandemic.

Request for Information (RFI): Inviting Comments and Suggestions on NIAID’s Strategic Plan

Responses to this RFI must be submitted via e-mail to: NIAIDStrategicPlanRFI@niaid.nih.gov

Responses must be received by May 27, 2024 at 11:59PM EST

The National Institute of Allergy and Infectious Diseases (NIAID) is updating its Strategic Plan, which will guide NIAID’s priorities over the next five years. This Notice is a Request for Information (RFI) inviting public feedback on NIAID’s proposed research priorities and cross-cutting themes.

Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.

1700 Owens Street | San Francisco, None 94158 US

This email was sent to .
To continue receiving our emails, add us to your address book.

Subscribe to our email list.